Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy.
A woman with inflammatory lesions in the terminal ileum was treated with sulphasalazine. Nine months later she developed angioimmunoblastic lymphadenopathy and was found to have intestinal villous atrophy. Her systemic illness partially responded to oral steroids but a gluten free diet restored clinical and biochemical well being coincident with a return of her villous pattern.
Smith
M A
MA
Steele
P R
PR
Youngs
G R
GR
D000368:Aged; D001284:Atrophy; D004386:Duodenum / Q000473:pathology; D005260:Female; D005983:Glutens / Q000008:administration & dosage; D006801:Humans; D007079:Ileitis / Q000178:diet therapy / Q000188:drug therapy*; D007119:Immunoblastic Lymphadenopathy / Q000139:chemically induced*; D008871:Microvilli; D012460:Sulfasalazine / Q000009:adverse effects*
D012460:Sulfasalazine; D005983:Glutens